These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7537956)

  • 21. [Urologic tumors in old age].
    Debruyne FM
    Tijdschr Gerontol Geriatr; 1986 Apr; 17(2):65-8. PubMed ID: 3715964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urological oncology in Europe. Research highlights from the XVIIth congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002.
    Thompson E
    Drugs Today (Barc); 2002 Apr; 38(4):221-34. PubMed ID: 12532191
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent advances in immuno-oncology and its application to urological cancers.
    Mataraza JM; Gotwals P
    BJU Int; 2016 Oct; 118(4):506-14. PubMed ID: 27123757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expanding role of artificial intelligence in the histopathological diagnosis in urological oncology: a literature review.
    Gurung J; Doykov M; Kostov G; Hristov B; Uchikov P; Kraev K; Doykov D; Doykova K; Valova S; Nacheva-Georgieva E; Tilkiyan E
    Folia Med (Plovdiv); 2024 Jun; 66(3):303-311. PubMed ID: 39365615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
    Seltz LM; Herrell SD
    Curr Opin Urol; 2016 May; 26(3):259-63. PubMed ID: 26914060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urologic cancer in China.
    Pang C; Guan Y; Li H; Chen W; Zhu G
    Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bladder cancer and prostate cancer in hemodialysis patients].
    Hatori M; Suzuki K; Yamanaka H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():374-7. PubMed ID: 15250328
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ultrasonics in urology. Historical review].
    Espuela Orgaz R; Torres Martínez C; Martínez Torres JL; Hozujk Issa N
    Arch Esp Urol; 1978; 31(2):187-204. PubMed ID: 358927
    [No Abstract]   [Full Text] [Related]  

  • 29. The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers.
    O'Brian D; Prunty M; Hill A; Shoag J
    Front Immunol; 2021; 12():721989. PubMed ID: 34512646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors.
    Barresi V; Ieni A; Cardia R; Licata L; Vitarelli E; Reggiani Bonetti L; Tuccari G
    APMIS; 2016 Mar; 124(3):188-93. PubMed ID: 26590121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor markers in the histopathology of urologic tumors].
    Hofstädter F
    Urologe A; 1987 Jan; 26(1):2-6. PubMed ID: 3576859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers.
    Ruiz de Porras V; Font A
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of urological tumours in pregnancy.
    Hendry WF
    Br J Urol; 1997 Jul; 80 Suppl 1():24-8. PubMed ID: 9240220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer.
    Suarez-Ibarrola R; Hein S; Reis G; Gratzke C; Miernik A
    World J Urol; 2020 Oct; 38(10):2329-2347. PubMed ID: 31691082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [De novo urologic tumors in kidney transplant patients].
    Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
    Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.
    Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M
    In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next revolution in molecular theranostics: personalized medicine for urologic cancers.
    Aoun F; Kourie HR; Artigas C; Roumeguère T
    Future Oncol; 2015; 11(15):2205-19. PubMed ID: 26235183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urology meeting highlights prostate, bladder cancers.
    Fillon M
    J Natl Cancer Inst; 2012 Sep; 104(18):1348-9. PubMed ID: 22984200
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
    Ouedraogo S; Traore MT; Kambire JL; Ouedraogo S; Bere B; Kabore AF
    Bull Cancer; 2019 Oct; 106(10):868-874. PubMed ID: 31350015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Response criteria for urological cancer treatment].
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):447-72. PubMed ID: 1593826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.